Literature DB >> 6801984

Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant.

F De Wolf, L O Carreras, P Moerman, J Vermylen, A Van Assche, M Renaer.   

Abstract

Evidence exists of an association between the presence of a "lupus" anticoagulant in plasma, recurrent fetal loss, and repeated thromboembolic accidents, also in the absence of systemic lupus erythematosus. Presented is an example of this association, with morphologic and biologic studies to elucidate its pathogenesis. In the case reported, the placenta showed massive infarction. In the spiral arteries of the basal plate of the placenta, lesions of intimal thickening, fibrinoid necrosis, acute atherosis, and intraluminal thrombosis were observed. The plasma of the patient contained a lupus anticoagulant and inhibited the formation of prostacyclin by rat aortic rings. Vascular production of prostacyclin is a major natural defense mechanism against thrombosis. Lack of generation of prostacyclin may account for the decidual vasculopathy and consequent placental infarction and for the generalized thrombotic tendency of some patients with lupus anticoagulant.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6801984     DOI: 10.1016/s0002-9378(16)32527-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  36 in total

Review 1.  Pregnancy and antibodies to phospholipids.

Authors:  M J Walport
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

2.  Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy.

Authors:  S Kobayashi; N Tamura; H Tsuda; C Mokuno; H Hashimoto; S Hirose
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

Review 3.  Antiphospholipid antibody-mediated reproductive failure in antiphospholipid syndrome.

Authors:  Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 4.  Evaluation of the obstetrical risks of the antiphospholipid syndrome and therapeutic management.

Authors:  P Edelman; A M Rouquette
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

Review 5.  Low molecular weight heparin in immunological recurrent abortion--the incredible cure.

Authors:  Gautam N Allahbadia; Swati G Allahbadia
Journal:  J Assist Reprod Genet       Date:  2003-02       Impact factor: 3.412

Review 6.  Anticardiolipin antibodies--clinical associations.

Authors:  R A Asherson; E N Harris
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

Review 7.  The antiphospholipid syndrome. Diagnosis, management, and pathogenesis.

Authors:  E N Harris
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

8.  Prevalence of antinuclear antibodies in patients with habitual abortion and in normal and toxemic pregnancies.

Authors:  I Garcia-De La Torre; L Hernandez-Vazquez; J Angulo-Vazquez; A Romero-Ornelas
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

9.  Antiphospholipid antibodies in systemic lupus erythematosus: clinical and laboratory associations in 111 patients.

Authors:  Y Wang; L Schrieber; M G Cohen; L Furphy; J Webb; T Chivers; K M Pollard
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

Review 10.  Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy.

Authors:  Michael D Lockshin
Journal:  Clin Lab Med       Date:  2013-04-19       Impact factor: 1.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.